Stay updated on DSP-5336 in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.

Latest updates to the DSP-5336 in Relapsed AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer. No study details, eligibility, contacts, or locations were altered.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's Locations section was updated to add numerous sites across multiple states and countries, and the page revision was updated to v3.3.3, while the HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%

- Check52 days agoChange DetectedMinor site revision from v3.3.1 to v3.3.2 observed on the page; no changes to the study details or navigation are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1 in the footer, with no other changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded recruitment site in Tainan, Taiwan. Updated Taiwan location naming from Tainan City, Taiwan to Tainan, Taiwan.SummaryDifference0.1%

- Check81 days agoChange DetectedThe Study Details page appears functionally unchanged; core sections such as overview, design, eligibility, and locations remain the same, with only minor visual formatting tweaks.SummaryDifference0.1%

Stay in the know with updates to DSP-5336 in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.